Peter Attia MD252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting
CHAPTERS
- 0:02 – 8:01
Rhonda's Evolved Thinking on Alzheimer's and Its Underlying Causes
Peter and Rhonda open by noting how both their views have evolved, then turn to Alzheimer's disease. Rhonda explains her personal stake, the limits of the amyloid hypothesis, and why she now looks for common underlying causes such as APOE4 and type 2 diabetes. Peter stresses that prevention is the key framing.
- •Rhonda has a family history of Alzheimer's and Parkinson's and carries a genetic predisposition
- •The amyloid hypothesis has produced many failed trials, raising the question of whether it targets symptoms too far downstream
- •APOE4 raises risk twofold with one copy and up to tenfold with two
- •Type 2 diabetes is present in a large share of people with Alzheimer's
- •Peter notes that preventive neurology is still on the outskirts of the field
- 8:01 – 16:02
The Blood-Brain Barrier and Why Its Breakdown Matters
Rhonda explains what the blood-brain barrier is and how tight junctions breaking down lets harmful molecules in while impairing nutrient transport and waste clearance. She discusses fibrinogen entering the brain and glymphatic clearance, and Peter adds his own connections to the mechanisms.
- •The barrier blocks unwanted substances while transporting oxygen, glucose, and nutrients
- •Permeability appears decades before cognitive impairment and in over 50% of dementias, independent of amyloid and tau
- •Glymphatic clearance during sleep requires an intact barrier
- •Fibrinogen leaking into the brain is toxic to myelin-making oligodendrocytes and linked to white matter lesions
- 16:02 – 20:17
How Type 2 Diabetes Damages the Brain via the Barrier
Peter asks about GLUT1 versus GLUT4 transporters, and Rhonda argues that diabetes harms the brain through mechanical disruption of the barrier rather than simply brain insulin resistance. Glycation and microvascular damage reduce blood flow and transporter function, giving a mechanism for the doubled Alzheimer's risk.
- •GLUT1 transports glucose into the brain and is largely insulin independent
- •Rhonda doubts the "type 3 diabetes" insulin resistance framing and favors barrier disruption
- •Advanced glycation end products and small vessel damage reduce flow and transporter function
- •Peter says diabetes acts through two prongs: microvasculature and direct glucose transport disruption
- 20:17 – 33:07
Omega-3 DHA, EPA, and Barrier Integrity
Rhonda describes the DHA transporter MFSD2A, its link to barrier integrity and pericytes, and how omega-3 status may matter for APOE4 carriers. They discuss the differing roles of DHA and EPA, anti-inflammatory effects, and Rhonda's new research collaboration.
- •MFSD2A transports DHA in lysophosphatidylcholine form; EPA and free DHA bound to albumin diffuse across
- •Disrupting MFSD2A in animals causes major barrier breakdown and large brain omega-3 loss
- •Rhonda has joined the Fatty Acid Research Institute for a grant on omega-3 and barrier biomarkers
- •Low fish omega-3 intake was named in a Harvard study as a top preventable cause of death, though Peter notes it may mark poor health
- •EPA and DHA both have inflammation-resolving roles, and EPA small trials suggest benefit for depression
- 33:07 – 36:29
Funding Bias, Prevention, and Late Intervention in Alzheimer's
Peter laments that money flows into doomed drug trials rather than prevention trials, and notes that coming late to Alzheimer's seems far less effective than in cardiovascular disease. Rhonda agrees that leaks are hard to fix once started and that low-dose omega-3 trials in patients are inadequate.
- •Peter says the cost of one failed phase three trial could fund a meaningful prevention trial
- •Financial incentives favor drug candidates over nutrient studies
- •Rhonda criticizes omega-3 trials in Alzheimer's patients that used very low doses
- •Rhonda says established disease will likely need a multi-angle cocktail, and prevention is the way to go
- 36:29 – 38:53
Inevitable vs. Preventable Diseases and Type 2 Diabetes as an Aging Accelerator
Peter distinguishes diseases he sees as inevitable, atherosclerosis and cancer, from type 2 diabetes, which he does not consider inevitable. Both agree diabetes amplifies the other major diseases and accelerates aging.
- •Peter considers atherosclerosis and cancer inevitable with enough age, but delayable
- •He does not believe type 2 diabetes is inevitable to our species
- •Diabetes raises risk of cardiovascular disease, cancer, and Alzheimer's
- •Peter calls it gasoline on the fire of aging
- 38:53 – 43:02
Blood Pressure and Dementia Risk
Peter asks whether blood pressure acts through the blood-brain barrier. Rhonda says it is a key modifiable factor, stresses cumulative exposure especially before age 50, and mentions exercise and sauna as ways to lower it.
- •Target systolic below 130, with Peter noting SPRINT suggests 120
- •Roughly 50% of US adults, and about 20% of those aged 18 to 39, have hypertension
- •Cumulative midlife exposure matters most for dementia risk
- •Exercise and sauna improve blood pressure; some people are salt-sensitive due to gene polymorphisms
- 43:02 – 51:28
Precision Nutrition and Why Nutrition Trials Are Hard
Peter asks how optimistic Rhonda is about gene-based precision nutrition in the next decade. She expects big progress, though funding incentives are a concern, and they discuss why nutrient trials, such as vitamin D trials, are often poorly designed.
- •Rhonda expects much more clarity within ten years, aided by cheaper technology and AI
- •Genetic differences affect responses to macronutrients and micronutrients like vitamin D, omega-3, and B vitamins
- •Drug trials start from zero levels, while nutrient trial participants may already have high levels
- •Peter says vitamin D trials should titrate to a target level rather than give a fixed low dose
- •A negative trial does not mean the thing does not work if the trial was poorly designed
- 51:28 – 1:01:06
How Exercise Protects the Brain: Intensity, Lactate, and BDNF
Peter asks about the mechanisms by which exercise lowers Alzheimer's risk. Rhonda explains why she emphasizes intensity, describing lactate as a fuel and signaling molecule that drives VEGF and BDNF and supports neurotransmitter synthesis.
- •Rhonda designs her workouts around neurobiological benefits and favors higher intensity
- •Lactate generated by muscle is consumed by the brain and signals VEGF to grow and repair vessels
- •BDNF supports long-term potentiation and neuroplasticity, and is increased by lactate and blood-flow shear force
- •Lactate also helps make glutamate and norepinephrine precursors
- 1:01:06 – 1:19:05
Training Protocols: Aerobic Pyramid, Tabata, and Blood Flow Restriction
Peter describes his aerobic pyramid of zone two base and VO2 max peaks, while Rhonda describes her daily Tabata-style routine on a Peloton. They compare approaches, including blood flow restriction, rest intervals, FTP testing, and minimum effective dose.
- •Peter's pyramid needs a wide zone two base and a high VO2 max peak, with four-minute repeats as his favorite
- •Rhonda does Tabata-style intervals five days a week, reaching about 7 to 8 mmol lactate
- •Peter suggests blood flow restriction to get high lactate while diversifying training
- •He suggests truly resting during off intervals, and the FTP test to set zones
- •High-intensity work drives mitochondrial biogenesis and suits people short on time
- 1:19:05 – 1:19:44
Cardiorespiratory Fitness and Dementia Risk
Rhonda describes a long-term study of women in which measured fitness was associated with sharply lower Alzheimer's risk, contrasting it with questionnaire-based studies. Peter explains why VO2 max is an objective readout, and they discuss possible sex differences in exercise response and myokines.
- •Women have roughly twofold higher Alzheimer's risk than men
- •Measured fitness in a decades-long study showed large risk reductions compared with a questionnaire study that showed none
- •Peter says VO2 max captures the result of training and is objective
- •Rhonda says sex differences in exercise response are plausible but she hasn't seen data
- •Myokines like irisin and IL-6 may affect the brain and cancer risk
- 1:19:44 – 1:33:45
Sauna, Hot Tubs, Memory, and Pregnancy
Peter asks how Rhonda fits sauna around exercise. She shares her temperatures, durations, reading and memory observations, hot tub use for sleep, and her decision to avoid sauna during pregnancy.
- •Rhonda uses dry sauna, steam, and hot tub; heat stress raises heat shock proteins and BDNF
- •She typically stays 20 to 30 minutes at 175 to 180°F, and found 190°F gave headaches and dehydration
- •She noticed better memory of talks rehearsed in the sauna
- •She avoided sauna during pregnancy out of caution about fetal risks
- •Her husband uses the hot tub at night to help his sleep
- 1:33:45 – 1:50:33
Exercise and Cancer Prevention and Recurrence
Peter asks how compelling the exercise and cancer data are. Rhonda reviews elite athlete studies, breast and colorectal cancer, aerobic exercise dose, circulating tumor cells and shear force, and Peter links the pattern to obesity-related cancers.
- •Olympian studies showed about two years saved from cancer but five to six years of total life extension
- •Breast and colorectal cancers appear most responsive, with 10 to 20% lower incidence in observational data
- •Exercise in diagnosed patients is linked to roughly 50% lower mortality and recurrence
- •Shear force from blood flow may kill circulating tumor cells
- •Rhonda calls exercise the only real panacea across cancer, dementia, cardiovascular disease, and diabetes
- 1:50:33 – 2:05:26
Proportional Risk: Hormone Therapy, Alcohol, and Sleep
Peter argues that people should allocate fear in proportion to effect size, using the Women's Health Initiative and hormone therapy as an example. The talk moves to alcohol and breast cancer, where Peter says no dose is healthy, then to APOE4 and alcohol, and exercise buffering poor sleep.
- •Peter says exercise also helps satiety signaling, and critiques the fear around hormone therapy relative to risks like obesity and drinking
- •Peter says there is no healthy dose of alcohol but low intake is hard to measure harm for
- •Peter says APOE4 carriers are more susceptible to alcohol and poor sleep
- •Rhonda's glucose monitor showed poor sleep dysregulated her glucose, blunted by a workout
- •Exercise may forgive many sins, including the mortality effect of poor sleep
- 2:05:26 – 2:25:33
Protein, Muscle Mass, and Rhonda's Shift Away from Animal Longevity Data
The conversation turns to the apparent conflict between low-protein longevity data and frailty in humans. Rhonda explains how exercise physiologists and the limits of mouse and C. elegans work changed her view, and Peter stresses sarcopenia and IGF-1 age nuances.
- •Low-protein benefits were confounded by lifestyle in human data
- •Rhonda argues sterile lab mice differ from humans in disease and muscle loss
- •Peter says avoiding sarcopenia requires adequate protein and strength training, and that the C. elegans IGF story is dogma
- •Exercise raises IGF-1 into muscle and brain, supporting adult neurogenesis in Rhonda's view
- •Peter says higher protein tracks IGF-1 in ages 50 to 65 but not over 65
- 2:25:33 – 2:35:35
How Much Protein, and How to Get It
They discuss revised protein targets, Stuart Phillips' re-examination of the RDA, anabolic resistance, and amino acid quality. Peter describes his meal and snack structure and how he uses protein with time restriction and GLP-1 agonists.
- •Rhonda says the minimum is closer to 1.2 g/kg than 0.8, and up to 1.6 to 1.8 for active or older people
- •Peter advises about one gram per pound and tracking leucine, lysine, and methionine for rigor
- •Peter eats four protein feedings, including a whey shake and venison jerky, and discloses he is an investor in the venison company
- •Peter prioritizes protein for patients on GLP-1 agonists, who risk losing muscle
- •Rhonda finds protein hard since exercise suppresses appetite
- 2:35:35 – 2:40:57
Fasting, Time-Restricted Eating, and Circadian Timing
Rhonda raises how her views on fasting and time-restricted eating shifted, since skipping meals can mean skipping protein. Peter explains that restricted windows limit protein utilization and discusses autophagy, and they agree that avoiding late-night eating has sleep and circadian value.
- •Time-restricted eating mainly works through caloric restriction in Rhonda's updated view
- •Peter says tiny feeding windows prevent adequate protein; protein snacks outside the window may be needed
- •He questions how meaningful fasting-induced autophagy is compared to exercise
- •Rhonda still sees cumulative circadian benefits of eating earlier
- •Both note late meals and alcohol impair sleep
- 2:40:57 – 2:53:27
Reassessing Beliefs, Following Rhonda's Work, and Lactate Research
Peter asks what else Rhonda believes differently now, and she defends updating views as data changes. They cover where to follow her work and her podcast history, and she returns to lactate and beta-hydroxybutyrate and their overlapping brain effects.
- •Rhonda says scientists should reassess as new data appears, including her supplements
- •She points to foundmyfitness.com articles, Instagram, Twitter, and her podcast
- •Her George Brooks podcast shifted her thinking on exercise intensity and lactate
- •Lactate and beta-hydroxybutyrate use the same MCT transporter and both may raise BDNF
- •Preliminary studies suggest lactate helps TBI patients and BHB may help cognition in Alzheimer's
